Denali Therapeutics’ Avlayah received FDA approval for treating Hunter syndrome, a rare neurological disorder. The biologic medicine uses Denali’s proprietary drug delivery technology to cross the protective blood-brain barrier.
The post FDA Approval for Denali Therapeutics Blazes a New Trail for Brain-Penetrating Drugs appeared first on MedCity News.
StealC you later: Proofpoint and IBM X-Force support Operation Endgame disruptions – IBM
StealC you later: Proofpoint and IBM X-Force support Operation Endgame disruptions IBM
